SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Bristol Myers Squibb pauses autoimmune trials after life-threatening side effects

Bristol Myers Squibb told regulators, researchers and patient groups in early June it paused closely watched drug research due to life-threatening side effects. The update reached the broader public three months later.

BMY

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories